|
SLAIN2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.098400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.971700E-02 |
| Normal-vs-Stage2 |
8.622100E-02 |
| Normal-vs-Stage3 |
3.899500E-02 |
| Normal-vs-Stage4 |
2.603700E-02 |
| Stage1-vs-Stage2 |
5.504600E-01 |
| Stage1-vs-Stage3 |
3.426200E-01 |
| Stage1-vs-Stage4 |
2.855600E-01 |
| Stage2-vs-Stage3 |
9.248800E-01 |
| Stage2-vs-Stage4 |
7.137400E-01 |
| Stage3-vs-Stage4 |
7.444800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.862400E-02 |
| Normal-vs-AfricanAmerican |
9.606600E-01 |
| Normal-vs-Asian |
7.725900E-02 |
| Caucasian-vs-AfricanAmerican |
1.889750E-01 |
| Caucasian-vs-Asian |
7.403600E-01 |
| AfricanAmerican-vs-Asian |
1.807600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.326360E-02 |
| Normal-vs-Female |
8.330200E-02 |
| Male-vs-Female |
1.622800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.981400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.652400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.682500E-02 |
| Normal-vs-Age(81-100Yrs) |
3.552600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.482000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.131800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.764600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.815800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.992600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.985000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.036200E-01 |
| Classical-VS-Follicular |
1.141180E-03 |
| Classical-VS-Other |
2.489800E-01 |
| Classical-VS-Normal |
3.988200E-01 |
| Tall-VS-Follicular |
1.641190E-01 |
| Tall-VS-Other |
3.856800E-01 |
| Tall-VS-Normal |
1.934160E-01 |
| Follicular-VS-Other |
9.362000E-01 |
| Follicular-VS-Normal |
1.482100E-03 |
| Other-VS-Normal |
1.004850E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.503600E-03 |
| Normal-vs-N1 |
7.512400E-02 |
| N0-vs-N1 |
6.460600E-01 |
|
|
